Cargando…
Microglial activation, white matter tract damage, and disability in MS
OBJECTIVE: To investigate the relationship of in vivo microglial activation to clinical and MRI parameters in MS. METHODS: Patients with secondary progressive MS (n = 10) or relapsing-remitting MS (n = 10) and age-matched healthy controls (n = 17) were studied. Microglial activation was measured usi...
Autores principales: | Rissanen, Eero, Tuisku, Jouni, Vahlberg, Tero, Sucksdorff, Marcus, Paavilainen, Teemu, Parkkola, Riitta, Rokka, Johanna, Gerhard, Alexander, Hinz, Rainer, Talbot, Peter S., Rinne, Juha O., Airas, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840890/ https://www.ncbi.nlm.nih.gov/pubmed/29520366 http://dx.doi.org/10.1212/NXI.0000000000000443 |
Ejemplares similares
-
Natalizumab treatment reduces microglial activation in the white matter of the MS brain
por: Sucksdorff, Marcus, et al.
Publicado: (2019) -
Adenosine A(2A) receptor availability in patients with early- and moderate-stage Parkinson’s disease
por: Waggan, Imran, et al.
Publicado: (2022) -
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
por: Bezukladova, Svetlana, et al.
Publicado: (2020) -
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
por: Sucksdorff, Marcus, et al.
Publicado: (2020) -
High serum neurofilament associates with diffuse white matter damage
in MS
por: Saraste, Maija, et al.
Publicado: (2020)